Literature DB >> 27511799

Heroin overdose.

Shane Darke1.   

Abstract

BACKGROUND AND AIMS: This narrative review aims to provide a brief history of the development of the heroin overdose field by discussing a selection of major 'classics' from the latter part of the 20th century.
METHODS: Papers considered landmarks were selected from 1972, 1977, 1983, 1984 and 1999.
RESULTS: Findings of earlier works suggest much of what later research was to demonstrate. These include arguing that overdoses occurred primarily among tolerant older users, that most 'overdose' deaths involved low morphine concentrations, that most overdoses involve polypharmacy, that drug purity has only a moderate influence on overdose rates and that instant death following heroin administration is rare.
CONCLUSIONS: Landmark studies of heroin overdose from the 1970s, 1980s and 1990s laid the foundations for subsequent overdose research, mainly by identifying the major demographic characteristics of overdose cases, risk factors, survival times and behaviours at overdose events.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  Circumstances; heroin; mechanisms; mortality; overdose; toxicology

Mesh:

Substances:

Year:  2016        PMID: 27511799     DOI: 10.1111/add.13516

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  11 in total

1.  Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroin.

Authors:  Joseph J Palamar; Austin Le; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-06-04       Impact factor: 4.492

2.  Overdose Research: 15 Years Later.

Authors:  Phillip O Coffin; Josiah D Rich
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

3.  Nonconsensual Dose Reduction Mandates are Not Justified Clinically or Ethically: An Analysis.

Authors:  Stefan G Kertesz; Ajay Manhapra; Adam J Gordon
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

4.  Changes in the development of opioid tolerance on re-exposure among people who use heroin: A qualitative study.

Authors:  Joanna May Kesten; Ed Holder; Rachel Ayres; Pete Ellis; Steve Taylor; Matthew Hickman; Graeme Henderson
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

Review 5.  The relationship between different dimensions of alcohol use and the burden of disease-an update.

Authors:  Jürgen Rehm; Gerhard E Gmel; Gerrit Gmel; Omer S M Hasan; Sameer Imtiaz; Svetlana Popova; Charlotte Probst; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Kevin D Shield; Paul A Shuper
Journal:  Addiction       Date:  2017-02-20       Impact factor: 6.526

6.  Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China.

Authors:  Shu Su; Limin Mao; Jinxian Zhao; Liang Chen; Jun Jing; Feng Cheng; Lei Zhang
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

7.  "Beyond Safer Injecting"-Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility.

Authors:  Vendula Belackova; Edmund Silins; Allison M Salmon; Marianne Jauncey; Carolyn A Day
Journal:  Int J Environ Res Public Health       Date:  2019-06-07       Impact factor: 3.390

Review 8.  Polysubstance use in the U.S. opioid crisis.

Authors:  Wilson M Compton; Rita J Valentino; Robert L DuPont
Journal:  Mol Psychiatry       Date:  2020-11-13       Impact factor: 15.992

Review 9.  Assessing Drug Consumption Rooms and Longer Term (5 Year) Impacts on Community and Clients.

Authors:  Vincent Tran; Sharon E Reid; Amanda Roxburgh; Carolyn A Day
Journal:  Risk Manag Healthc Policy       Date:  2021-11-15

10.  Association between recreational drug use and sexual practices among people who inject drugs in Southwest China: a cross-sectional study.

Authors:  Lei Zhang; Feng Cheng; Shu Su; Shunxiang Li; Shifu Li; Jun Jing; Christopher Kincaid Fairley; Liang Chen; Jinxian Zhao; Limin Mao
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.